Editorial: Developing therapeutics for antimicrobial resistant pathogens

Raja Veerapandian; Parveez Ahamed Abdul Azees; Thiruselvam Viswanathan; Bennett Tochukwu Amaechi; Govindsamy Vediyappan

doi:10.3389/fcimb.2022.1083501

Editorial: Developing therapeutics for antimicrobial resistant pathogens

Front Cell Infect Microbiol. 2022 Nov 24:12:1083501. doi: 10.3389/fcimb.2022.1083501. eCollection 2022.

Authors

Raja Veerapandian¹, Parveez Ahamed Abdul Azees², Thiruselvam Viswanathan³, Bennett Tochukwu Amaechi², Govindsamy Vediyappan⁴

Affiliations

¹ Center of Emphasis in Infectious Diseases, Department of Molecular and Translational Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, TX, United States.
² Department of Comprehensive Dentistry, School of Dentistry, University of Texas Health Science Center at San Antonio, San Antonio, TX, United States.
³ Department of Cellular Biology and Pharmacology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, United States.
⁴ Division of Biology, Kansas State University, Manhattan, KS, United States.

No abstract available

Keywords: anti-biofilm drugs; anti-virulence drugs; antibiotic- antibody combination therapy; drugs; in silico drug design; nanotechnology; repurposed drugs.

Publication types

Editorial

MeSH terms

Anti-Infective Agents*

Substances

Anti-Infective Agents